NanoGram Acquisition Powers Wilson Greatbatch With Battery R&D
This article was originally published in The Gray Sheet
Executive Summary
Wilson Greatbatch will look to shrink its forthcoming Quasar implant batteries with nanoscale materials technology gained through the acquisition of competitor NanoGram Devices (NGD)
You may also be interested in...
Pacemaker Battery Supplier Focuses On Nano R&D As Guidant Orders Slip
Wilson Greatbatch plans to curb reliance on Guidant by building on a 31% growth rate for second-quarter sales of pacemaker batteries to other cardiac rhythm management firms
Pacemaker Battery Supplier Focuses On Nano R&D As Guidant Orders Slip
Wilson Greatbatch plans to curb reliance on Guidant by building on a 31% growth rate for second-quarter sales of pacemaker batteries to other cardiac rhythm management firms
Wilson Greatbatch Sees Wide Applicability Of Quasar Battery Starting In 2005
Implant component supplier Wilson Greatbatch anticipates that its new Quasar batteries will be incorporated in cardiac rhythm management devices "across the board," upon availability in 2005